NNRX Nutranomics Inc (CE)

Item 1(a). Name of Issuer:

Nutranomics, Inc. (the “Issuer”)

Item 1(b). Address of Issuer’s Principal Executive Offices:

The Issuer’s principal executive offices are located at 605 Portland Ave., Ste. 154, Gladstone, OR 97027

Item 2(a). Names of Persons Filing:

This statement is filed by:

The foregoing persons are hereinafter sometimes individually referred to as a “Reporting Person” and collectively referred to as the “Reporting Persons”. Any disclosures herein with respect to persons other than the Reporting Persons are made on information and belief after making inquiry to the appropriate party.

The Reporting Persons have entered into a Joint Filing Agreement, a copy of which is filed with this Schedule 13G as Exhibit 1, pursuant to which they have agreed to file this Schedule 13G jointly in accordance with the provisions of Rule 13d-1(k) of the Act.

The filing of this statement should not be construed in and of itself as an admission by any Reporting Person as to beneficial ownership of the securities reported herein.

Item 2(b). Address of Principal Business Office or, if none, Residence:

The principal business address of the Reporting Person is 2338 Immokalee Road, Naples, FL 34110

Item 2(c). Citizenship:

Trillium is a limited partnership organized under the laws of Delaware. Maple Leaf is a limited liability company organized under the laws of Delaware. Frondeur Partners LLC is a limited liability company organized under the laws of Nevada. Mr. Hicks is a citizen of Canada.

Item 2(d). Title of Class of Securities:

The title of the class of securities to which this statement relates is the Common Stock of the Issuer, $0.0001 par value per share (the “Common Stock”)

Item 2(e). CUSIP Number:

67060H108

Item 3. If This Statement is Filed Pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), Check Whether the Person Filing is a:

Not applicable.

Item 4. Ownership.

The information required by this item with respect to each Reporting Person is set forth in Rows 5 through 9 and 11 of the cover page to this Schedule 13G and is incorporated herein by reference for each such Reporting Person. The ownership percentages reported are based on 15,324,654,045 shares of Common Stock issued and outstanding as of October 12, 2022, and includes shares of Common Stock that are issuable upon the conversion of certain convertible notes in the aggregate principal amount of $1,665,400 (the “Notes”), 1,000,000 shares of Series C preferred stock (the “Preferred Stock”), and warrants (“Warrants”) of Issuer held by Reporting Person, subject to a limitation on beneficial ownership described below.

As of October 25, 2022, Trillium holds 1,212,292,000 shares of Common Stock, (the “Common Stock Shares”), and has the right to acquire additional shares of Common Stock through the conversion of the Notes and the Preferred Stock, and upon exercise of the Warrants, up to but not exceeding 9.99% of the Issuer’s outstanding Common Stock at any time. Trillium has the power to dispose of and the power to vote the Common Stock Shares beneficially owned by it, which power may be exercised by its general partner, Maple Leaf, and its manager, Mr. Hicks. Maple Leaf and Mr. Hicks have shared power to vote and/or dispose of the Shares beneficially owned by Trillium. Neither Maple Leaf nor Mr. Hicks directly owns any shares of Common Stock of the Issuer. By reason of the provisions of Rule 13d-3 of the Act, each of Maple Leaf and Mr. Hicks may be deemed to beneficially own the Shares beneficially owned by Trillium. 

As of October 25, 2022, Frondeur holds convertible notes in the aggregate principal amount of $60,000.00, which are convertible into shares of Common Stock. The Notes may not be converted into Common Stock such that the Reporting Person, together with its affiliates and other attribution parties, would beneficially own more the 9.99% of the Issuer’s Common Stock at any time. Frondeur has the power to convert the Notes into Common Stock, which power may be exercised by Mr. Hicks. Mr. Hicks does not directly own the Notes held by Frondeur. Mr. Hicks may be deemed a beneficial owner, for purposes of Section 13(d) of the Act, of any securities of the Issuer beneficially owned by Frondeur. Mr. Hicks disclaims ownership of the securities reported in this Schedule 13G Statement (the “Statement”) other than for the purpose of determining the obligations under Section 13(d) of the Act, and the filing of the Statement shall not be deemed an admission that Mr. Hicks is the beneficial owner of such securities for any other purpose.

Item 5. Ownership of Five Percent or Less of a Class.

If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than five percent of the class of securities, check the following ☐.

Item 6. Ownership of More than Five Percent on Behalf of Another Person.

Not applicable.

Item 7. Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.

Not applicable.

Item 8. Identification and Classification of Members of the Group.

Not applicable.

Item 9. Notice of Dissolution of Group.

Not applicable.

Item 10. Certification.

By signing below, I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

EXHIBIT 1

JOINT FILING AGREEMENT

PURSUANT TO RULE 13d-1(k)

The undersigned acknowledge and agree that the foregoing statement on Schedule 13G is filed on behalf of each of the undersigned and that all subsequent amendments to this statement on Schedule 13G shall be filed on behalf of each of the undersigned without the necessity of filing additional joint filing agreements. The undersigned acknowledge that each shall be responsible for the timely filing of such amendments, and for the completeness and accuracy of the information concerning him or it contained herein and therein, but shall not be responsible for the completeness and accuracy of the information concerning the others, except to the extent that he or it knows or has reason to believe that such information is inaccurate. The undersigned hereby further agree that this Joint Filing Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original, but all of which counterparts shall together constitute one and the same instrument.